Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Low Rate of Primary Hyperlipidemia Screening Reported in RA Patients

Key clinical point: A retrospective study suggests the frequency of primary lipid screening is lower among patients with rheumatoid arthritis (RA) compared with diabetes mellitus (DM).

Major finding: Among participants with RA and DM, RA alone, DM alone, or neither disease, the rates of lipid screening were 55%, 37%, 60%, and 41%, respectively.

Study details: A claims-based retrospective analysis of 243,909 eligible participants, 12,182 of whom had RA.

Disclosures: The study was funded by the National Institutes of Health. No potential conflicts of interest were reported.

Citation:

Navarro-Millán I et al. Arthritis Care Res. 2019 Dec;71(12):1593-9. doi: 10.1002/acr.23810.